Procter & Gamble
PG
$145.27
+1.61%
Procter & Gamble (PG) is a global consumer products giant, manufacturing and selling a diversified portfolio of household and personal care brands, including Tide, Charmin, Pantene, and Pampers, across more than 180 countries. As one of the world's largest consumer packaged goods companies, P&G holds leadership positions in numerous categories, with over 20 brands generating more than $1 billion in annual sales each. The current investor narrative centers on P&G's ability to navigate a challenging operating environment marked by input cost inflation, sluggish volume growth, and cautious guidance, while the stock trades near its 52-week low, prompting debates about its value proposition as a defensive dividend play versus concerns about its growth trajectory.…
PG
Procter & Gamble
$145.27
Related headlines
Investment Opinion: Should I buy PG Today?
Based on the data, I rate PG as a Hold. The stock offers a defensive profile with a 2.88% dividend yield and a low beta of 0.377, but its growth prospects are limited, and the valuation is not compelling. The average analyst target of $160.61 implies a modest 9.7% upside, which is insufficient to justify a Buy given the risks. Key metrics include a trailing PE of 21.72x, forward PE of 19.79x, and a PEG of 18.11x, indicating that the market is paying a premium for low growth. Revenue growth of 7.4% in the latest quarter is encouraging, but volume declines and guidance below estimates temper optimism. The stock is fairly valued relative to its history, but not undervalued, and a Buy would require a price below $140 or a clear catalyst for volume recovery.
Sign up to view all
PG 12-Month Price Forecast
The AI model assesses PG as neutral with medium confidence. The stock offers defensive qualities and a reasonable dividend, but its growth is limited and valuation is not cheap. The key swing factor is volume recovery; if volumes return, the stock could outperform, but if not, it may continue to lag. The model would upgrade to bullish if volume growth turns positive and guidance improves, and downgrade to bearish if cost headwinds worsen or the stock breaks below $137.62.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $160.61 and implied upside of +10.6% versus the current price.
Average Target
$160.61
0 analysts
Implied Upside
+10.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$143 - $186
Analyst target range
The target price range spans from a low of $143.00 to a high of $186.00, with the low target slightly below the current price, suggesting some analysts see downside risk, while the high target implies a 27% upside. The wide spread of $43 (30% of the average target) reflects significant uncertainty about P&G's future performance, likely due to concerns about volume recovery and cost pressures. Recent ratings actions have been predominantly neutral to positive, with no downgrades in the last few months, indicating that analysts are maintaining their positions while awaiting clearer signs of a turnaround.
Bulls vs Bears: PG Investment Factors
PG presents a classic value-versus-growth dilemma. The bull case rests on its defensive qualities, high margins, strong cash flow, and a Buy rating from analysts, while the bear case highlights weak volume, high valuation, and disappointing guidance. Currently, the bearish evidence is slightly stronger given the stock's persistent downtrend and the market's focus on growth. The most critical tension is whether P&G can restore volume growth and offset cost headwinds; if it can, the stock is undervalued, but if not, the premium valuation could compress further.
Bullish
- Strong Q3 revenue acceleration: Q3 FY2026 revenue grew 7.4% YoY to $21.235B, a sharp acceleration from the prior quarter's 1.5% growth, signaling improving demand and pricing power despite a challenging environment.
- High profitability and margins: Gross margin stands at 50.2%, operating margin at 22.7%, and net margin at 18.4%, reflecting P&G's ability to maintain pricing and cost discipline, with ROE at 29.5% indicating efficient capital use.
- Defensive low-beta profile: With a beta of 0.377, PG offers significant downside protection during market volatility, making it an attractive defensive holding, especially as some analysts suggest rotating from high-flying tech into staples.
- Analyst consensus is Buy: The average analyst target of $160.61 implies ~9.7% upside from the current price of $146.44, with a consensus rating of 'Buy' and no recent downgrades, suggesting analysts see value at current levels.
Bearish
- Guidance below expectations: Fiscal 2027 guidance came in below estimates due to $1.36B in cost headwinds, raising concerns about near-term earnings growth and pressuring the stock, which sits near its 52-week low.
- Volume remains under pressure: Despite revenue growth, volume declined, indicating that growth is price-driven rather than demand-driven, which may not be sustainable if consumers resist further price increases.
- High valuation with low growth: The PEG ratio is extremely high at 18.11x, reflecting that the market is paying a premium for limited growth, making the stock vulnerable to multiple compression if growth disappoints.
- Underperformance vs market: PG is down 8.0% over the past year while the S&P 500 gained 18.65%, and relative strength is negative across all timeframes, indicating persistent selling pressure and weak momentum.
PG Technical Analysis
PG's price trend over the past year is clearly bearish, with the stock down 8.0% over the last 12 months, significantly underperforming the S&P 500's +18.65% gain. The current price of $146.44 sits at 29.6% of its 52-week range (between $137.62 low and $167.25 high), indicating the stock is trading near the lower end of its yearly range. This positioning suggests a downtrend or prolonged consolidation, with the stock having lost momentum after peaking above $167, and it now faces resistance at former support levels.
Beta
0.38
0.38x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-8.4%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | +0.8% | -1.1% |
| 3m | -2.9% | +3.0% |
| 6m | -3.6% | +15.4% |
| 1y | -8.4% | +16.2% |
| ytd | +2.5% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
In the most recent quarter (Q3 FY2026, ended March 31, 2026), P&G reported revenue of $21.235 billion, a 7.4% increase year-over-year, marking an acceleration from the prior quarter's 1.5% growth. However, this growth was primarily price-driven, as volume remained under pressure, and the company's guidance for fiscal 2027 came in below expectations due to $1.36 billion in cost headwinds. Revenue segments show Fabric Care and Home Care as the largest contributor at $7.403 billion, followed by Baby, Feminine and Family Care at $5.058 billion, with Beauty at $3.866 billion, Health Care at $3.073 billion, and Grooming at $1.608 billion, indicating broad-based but modest growth across categories.
Quarterly Revenue
$21.2B
2026-03
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
49.5%
Latest Quarter
Free Cash Flow
$15.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
Given P&G's positive net income, the PE ratio is the primary valuation metric. The trailing PE stands at 21.72x, while the forward PE is 19.79x, implying the market expects earnings growth of about 9.8% over the next year. This gap suggests a modest growth expectation, consistent with P&G's mature industry status. The stock's PEG ratio is notably high at 18.11x, indicating that the market is paying a premium for the limited growth P&G offers, which may deter growth-oriented investors.
PE
21.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, PG faces risks from its high payout ratio of 63.8%, which limits flexibility to reinvest in growth or weather earnings downturns. The company's debt-to-equity ratio of 0.645 is manageable, but its current ratio of 0.677 indicates potential liquidity strain, though this is typical for consumer staples with steady cash flows. The $1.36B cost headwinds for fiscal 2027 could pressure margins, which are already high at 50.2% gross and 22.7% operating, leaving limited room for error. Additionally, revenue concentration in Fabric and Home Care (35% of sales) exposes PG to category-specific downturns.
FAQ
The key risks of holding PG include: 1) Financial risk from high payout ratio of 63.8% and cost headwinds of $1.36B, which could pressure earnings and dividend growth. 2) Competitive risk from private-label brands and other consumer staples companies that may undercut prices, leading to volume losses. 3) Macro risk from rising interest rates, which could make the stock's dividend yield less attractive relative to bonds, and a strong dollar, which could hurt international sales. 4) Company-specific risk of continued volume declines, as seen in recent quarters, which could signal a loss of market share. The most severe risk is a combination of these factors leading to a break below the 52-week low of $137.62, potentially resulting in a 10-15% loss from current levels.
The 12-month forecast for PG is mixed. The bull case, with a 25% probability, targets $160-$186, driven by volume recovery and market rotation into defensives. The base case, with a 50% probability, targets $146-$161, assuming steady but unspectacular performance. The bear case, with a 25% probability, targets $130-$143, if cost pressures and volume declines persist. The most likely scenario is the base case, where the stock trades around the average analyst target of $160.61, providing a modest 9.7% return. However, the stock's near-term momentum is negative, and a break below $137.62 could lead to a more bearish outcome.
PG is fairly valued relative to its history, with a trailing PE of 21.72x and forward PE of 19.79x, which are in line with its five-year average. However, the PEG ratio of 18.11x is extremely high, indicating that the market is paying a premium for the company's limited growth. Compared to the broader market, PG's PE is higher than the S&P 500's average, but this is typical for defensive staples. The valuation implies that investors expect steady, but not spectacular, earnings growth of around 9.8% over the next year. Given the low growth prospects, the stock is not undervalued, but it is also not excessively overvalued, making it a fair hold for income investors.
PG is a good buy for income-focused investors seeking a defensive holding with a 2.88% dividend yield and low beta of 0.377. However, the stock's growth is limited, and the valuation is not cheap, with a forward PE of 19.79x. The average analyst target of $160.61 implies a 9.7% upside, which is modest. The biggest risk is continued volume declines and cost pressures, which could lead to further downside. For growth-oriented investors, PG may not be attractive, but for those prioritizing stability and income, it is a reasonable buy at current levels, especially if the price drops below $140.
PG is more suitable for long-term investment due to its defensive nature, low beta of 0.377, and reliable dividend income. The stock is unlikely to provide significant short-term gains, as its growth is limited and the technical trend is bearish. For long-term investors, PG offers a stable income stream and potential for modest capital appreciation, making it a good fit for a diversified portfolio. A minimum holding period of 3-5 years is recommended to ride out market cycles and benefit from dividend compounding. Short-term traders may find better opportunities elsewhere, as PG's low volatility and lack of catalysts make it less attractive for trading.